FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025314483> ?p ?o ?g. }

• W2025314483 endingPage "1236" @default.
• W2025314483 startingPage "1228" @default.
• W2025314483 abstract "Our aim was to determine the efficacy of 1 g azithromycin and alternative antibiotic regimens in a prospective cohort of Mycoplasma genitalium-infected participants, and factors associated with azithromycin failure.Consecutive eligible M. genitalium-infected men and women attending the Melbourne Sexual Health Centre between July 2012 and June 2013 were treated with 1 g of azithromycin and retested by polymerase chain reaction (PCR) on days 14 and 28. Cure was defined as PCR negative on day 28. Cases failing azithromycin were treated with moxifloxacin, and those failing moxifloxacin were treated with pristinamycin. Pre- and posttreatment samples were assessed for macrolide resistance mutations (MRMs) by high-resolution melt analysis. Mycoplasma genitalium samples from cases failing moxifloxacin were sequenced for fluoroquinolone resistance mutations. Multivariable analysis was used to examine associations with azithromycin failure.Of 155 participants treated with 1 g azithromycin, 95 (61% [95% confidence interval {CI}, 53%-69%]) were cured. Pretreatment MRM was detected in 56 (36% [95% CI, 28%-43%]) participants, and strongly associated with treatment failure (87% [95% CI, 76%-94%]; adjusted odds ratio, 47.0 [95% CI, 17.1-129.0]). All 11 participants who had MRM detected in posttreatment samples failed azithromycin. Moxifloxacin was effective in 53(88% [95% CI, 78%-94%]) of 60 cases failing azithromycin; all failures had gyrA and parC mutations detected in pretreatment samples. Six of 7 patients failing moxifloxacin treatment received pristinamycin, and all were PCR negative 28 days after pristinamycin treatment.We report a high azithromycin failure rate (39%) in an M. genitalium-infected cohort in association with high levels of pretreatment macrolide resistance. Moxifloxacin failure occurred in 12% of patients who received moxifloxacin; all had pretreatment fluoroquinolone mutations detected. Pristinamycin was highly effective in treating macrolide- and quinolone-resistant strains." @default.
• W2025314483 created "2016-06-24" @default.
• W2025314483 creator A5008481687 @default.
• W2025314483 creator A5013829756 @default.
• W2025314483 creator A5016270380 @default.
• W2025314483 creator A5018026058 @default.
• W2025314483 creator A5021211026 @default.
• W2025314483 creator A5033943773 @default.
• W2025314483 creator A5056904986 @default.
• W2025314483 creator A5058438440 @default.
• W2025314483 creator A5079073841 @default.
• W2025314483 creator A5085557255 @default.
• W2025314483 creator A5086010156 @default.
• W2025314483 date "2014-12-23" @default.
• W2025314483 modified "2023-10-14" @default.
• W2025314483 title "Macrolide Resistance and Azithromycin Failure in a Mycoplasma genitalium-Infected Cohort and Response of Azithromycin Failures to Alternative Antibiotic Regimens" @default.
• W2025314483 cites W193182446 @default.
• W2025314483 cites W1964734241 @default.
• W2025314483 cites W1985800413 @default.
• W2025314483 cites W1986570488 @default.
• W2025314483 cites W2013172437 @default.
• W2025314483 cites W2020025309 @default.
• W2025314483 cites W2022165979 @default.
• W2025314483 cites W2029772902 @default.
• W2025314483 cites W2032496494 @default.
• W2025314483 cites W2046672558 @default.
• W2025314483 cites W2053461898 @default.
• W2025314483 cites W2060587528 @default.
• W2025314483 cites W2075984439 @default.
• W2025314483 cites W2080798045 @default.
• W2025314483 cites W2093596950 @default.
• W2025314483 cites W2095470079 @default.
• W2025314483 cites W2104762786 @default.
• W2025314483 cites W2105411629 @default.
• W2025314483 cites W2111328449 @default.
• W2025314483 cites W2112313501 @default.
• W2025314483 cites W2112977116 @default.
• W2025314483 cites W2113364854 @default.
• W2025314483 cites W2113705692 @default.
• W2025314483 cites W2125342917 @default.
• W2025314483 cites W2130271192 @default.
• W2025314483 cites W2130737566 @default.
• W2025314483 cites W2131633779 @default.
• W2025314483 cites W2135467493 @default.
• W2025314483 cites W2141167262 @default.
• W2025314483 cites W2148669519 @default.
• W2025314483 cites W2152398215 @default.
• W2025314483 cites W2157031519 @default.
• W2025314483 cites W2157755311 @default.
• W2025314483 cites W2162246504 @default.
• W2025314483 cites W2164950865 @default.
• W2025314483 cites W2167772364 @default.
• W2025314483 cites W2316357258 @default.
• W2025314483 doi "https://doi.org/10.1093/cid/ciu1162" @default.
• W2025314483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25537875" @default.
• W2025314483 hasPublicationYear "2014" @default.
• W2025314483 type Work @default.
• W2025314483 sameAs 2025314483 @default.
• W2025314483 citedByCount "146" @default.
• W2025314483 countsByYear W20253144832015 @default.
• W2025314483 countsByYear W20253144832016 @default.
• W2025314483 countsByYear W20253144832017 @default.
• W2025314483 countsByYear W20253144832018 @default.
• W2025314483 countsByYear W20253144832019 @default.
• W2025314483 countsByYear W20253144832020 @default.
• W2025314483 countsByYear W20253144832021 @default.
• W2025314483 countsByYear W20253144832022 @default.
• W2025314483 countsByYear W20253144832023 @default.
• W2025314483 crossrefType "journal-article" @default.
• W2025314483 hasAuthorship W2025314483A5008481687 @default.
• W2025314483 hasAuthorship W2025314483A5013829756 @default.
• W2025314483 hasAuthorship W2025314483A5016270380 @default.
• W2025314483 hasAuthorship W2025314483A5018026058 @default.
• W2025314483 hasAuthorship W2025314483A5021211026 @default.
• W2025314483 hasAuthorship W2025314483A5033943773 @default.
• W2025314483 hasAuthorship W2025314483A5056904986 @default.
• W2025314483 hasAuthorship W2025314483A5058438440 @default.
• W2025314483 hasAuthorship W2025314483A5079073841 @default.
• W2025314483 hasAuthorship W2025314483A5085557255 @default.
• W2025314483 hasAuthorship W2025314483A5086010156 @default.
• W2025314483 hasBestOaLocation W20253144831 @default.
• W2025314483 hasConcept C126322002 @default.
• W2025314483 hasConcept C159047783 @default.
• W2025314483 hasConcept C2777391075 @default.
• W2025314483 hasConcept C2778836808 @default.
• W2025314483 hasConcept C2778907293 @default.
• W2025314483 hasConcept C2780062933 @default.
• W2025314483 hasConcept C501593827 @default.
• W2025314483 hasConcept C71924100 @default.
• W2025314483 hasConcept C72563966 @default.
• W2025314483 hasConcept C86803240 @default.
• W2025314483 hasConcept C89423630 @default.
• W2025314483 hasConceptScore W2025314483C126322002 @default.
• W2025314483 hasConceptScore W2025314483C159047783 @default.
• W2025314483 hasConceptScore W2025314483C2777391075 @default.
• W2025314483 hasConceptScore W2025314483C2778836808 @default.
• W2025314483 hasConceptScore W2025314483C2778907293 @default.
• W2025314483 hasConceptScore W2025314483C2780062933 @default.

• next